The lack of breakthrough treatments for mesothelioma in recent years is because the cancer is not associated with a single genetic mutation that can be targeted, a UK expert told COSA 2018 in Perth. But the successful genome mapping of mesothelioma tumour cells by Australian and UK researchers has opened the door to personalised cancer ...
Quest for mesothelioma treatments centres on genomic vulnerabilities
By Michael Woodhead
15 Nov 2018